[HTML][HTML] Double Duty: SGLT2 Inhibitors as Cardioprotective and Anticancer Allies

L Piras, M Zuccanti, G Tini Melato, M Volpe, G Tocci… - Hearts, 2024 - mdpi.com
Sodium glucose cotransporter-2 inhibitors (SGLT2i), originally developed for type II diabetes
mellitus, have recently been approved for the treatment of heart failure in both diabetic and …